[Thrombolytic medication. Theoretical and practical aspects].
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001018:Aortic Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D004438:Ecchymosis / Q000139:chemically induced; D004617:Embolism / Q000188:drug therapy*; D005260:Female; D006406:Hematoma / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced; D008297:Male; D008881:Migraine Disorders / Q000139:chemically induced; D009203:Myocardial Infarction / Q000188:drug therapy*; D010689:Phlebitis / Q000150:complications; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*
D000925:Anticoagulants; D013300:Streptokinase
Medicaţia trombolitică. Aspecte teoretice şi practice